# Hillgene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hillgene

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.hillgene.com
- Latest round: Series A (Apr 7, 2023)
- Investors on record: 10

## About

Based in Suzhou, China and founded in 2017, Jiangsu Puxin Bio-pharmaceutical Co., Ltd., doing business named as Hillgene, operates as a cell and gene therapy drug solutions provider, focusing on cellular therapy drugs. The company also established two GMP manufacturing sites in Shenzhen and Shanghai. And the North Carolina site in the US is under construction. Its GMP facility covers over 18,000 square meters. Moreover, it submissions 6 IND, and has over 200 prepared cells for clinical use. As of FY2023, the company's cumulative order book exceeds RMB600 million and is 100% cell therapy CDMO (Contract Development & Manufacturing Organization) orders. In August 2023, it raised series A+ funding from returning investor Shengxingzhe Equity Investment.

The company focuses on the field of cellular therapeutics, we have built a plasmid construction platform for cellular drugs, a suspension serum-free virus production platform and a fully enclosed cellular process development platform. Hillgene provides reagent kits for plasmids, mRNA, lentivirus, viruses, antibodies, and, CAR-T. It established technology platforms including nucleic acid, CDMO services platform, lentiviral vectors, immune cells, and stem cells. The company also provides cell CDMO services, lentiviral CDMO services, and plasmid CDMO services. Besides, it also provides testing services and pharmacy quality control research.

## Funding rounds

- Series A, Apr 7, 2023 — Jiarui Investment, Hesheng Capital
- Angel, Jul 13, 2021 — CASH Capital, Hunan Hi-Tech Venture Capital, Shenzhen Guozhong Venture Capital, Huapont Life Science, China Securities, Yuanzhi Venture Capital, Zhengxu Capital, Shengxingzhe Equity Investment

## Investors

- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Angel
- Hunan Hi-Tech Venture Capital (https://capitalatlas.ai/funds/hunan-hi-tech-venture-capital) — Angel
- Shenzhen Guozhong Venture Capital (https://capitalatlas.ai/funds/shenzhen-guozhong-venture-capital) — Angel
- Huapont Life Science — Angel
- China Securities — Angel
- Yuanzhi Venture Capital (https://capitalatlas.ai/funds/yuanzhi-venture-capital) — Angel
- Zhengxu Capital (https://capitalatlas.ai/funds/zhengxu-capital) — Angel
- Shengxingzhe Equity Investment — Angel
- Jiarui Investment (https://capitalatlas.ai/funds/jiarui-investment) — Series A
- Hesheng Capital — Series A